Countless people who took Lipitor (Atorvastatin) and were later diagnosed with type 2 diabetes are seeking to hold Pfizer and its distributors responsible. In California, cases filed throughout the State have been coordinated before Judge Jane Johnson in Los Angeles with an initial status conference held on February 25, 2014. (See JCCP 4761). Judge Johnson [...]
Big Pharma: Is Paying Big Fines More Profitable than Telling Doctors and Consumers the Truth in Marketing?
This week, Johnson & Johnson etched its name in the history books of another big pharma company that has been fined over billions of dollars due to a drug manufacturer practices of improper marketing and failure to warn. Johnson & Johnson pled guilty to claims stemming from allegations that the giant pharmaceutical company knowingly marketed [...]
Dr. Eric Topol is a cardiologist with the Scripps Clinic and a recognized pioneer in the field of cardiovascular medicine. For fourteen years, he ran the Cleveland Health Clinic, has authored over 1100 articles and 30 books, and was a founder of the Cleveland Clinic Lerner College of Medicine. An OP Ed article he wrote [...]
Body Mass Index (BMI) Chart for Evaluation of New Onset Diabetes while taking Lipitor, Crestor, or other Statins
In January of 2012, a study published in the medical journal Archives of Internal Medicine found that female patients between the ages of 50 and 79 who took statin medications (i.e., Lipitor and other LDL-lowering drugs) were 48 percent more likely to develop type 2 diabetes as compared to women in the same age group [...]